Tri-State Health Services

What Tri-State Health Services does

Tri-State Health Services, LLC is a privately held outpatient addiction medicine practice headquartered at 400 Jefferson Ave, Suite 3, Washington, Pennsylvania. The company provides medication-assisted treatment (MAT) for individuals addicted to prescription pain medications and heroin. Its clinical offering is built on FDA-approved pharmacotherapies — buprenorphine-based products including Suboxone, Zubsolv, Bunavail, and Subutex, plus naltrexone (Vivitrol) — combined with psychotherapy, counseling, and case management. The practice is certified under the Drug Addiction Treatment Act of 2000 (DATA 2000), which authorizes office-based prescribing of buprenorphine, and it serves patients across Pennsylvania, Ohio, and West Virginia from a single physical site with evening and weekend availability.

The business operates as a professional services clinical practice, generating revenue through per-visit fees, medication management, and ongoing maintenance programs, typically reimbursed through insurance or direct patient payment (pricing not publicly disclosed). The primary customer segment is individuals with opioid use disorder, including patients who have previously failed faith-based or 12-step programs, pregnant patients (Subutex), and individuals requiring court or legal compliance documentation. The company maintains referral relationships with local Community Service Boards, psychiatric facilities, and outpatient resources, and it differentiates by offering non faith-based counseling options.

Strategically, Tri-State Health Services is a single-site, independently operated LLC with no disclosed funding rounds, investors, parent company, executive team, M&A activity, or geographic expansion beyond its tri-state marketing footprint. Its growth posture is that of a stable community clinic rather than a scaling platform: there is no technology platform, no digital product, no mobile application, no API or integrations, and no AI/ML capability disclosed. Distribution is exclusively via direct in-office visits and organic social media channels (Facebook, Twitter, Google+, YouTube). The practice's competitive position rests on its DATA 2000 certification, its specialized clinical expertise in opioid addiction, and its differentiated patient-centered approach combining medication treatment with psychotherapy in a region with documented opioid abuse challenges.

Name

Tri-State Health Services

Legal name

Tri-State Health Services, LLC.

Website

https://tshealthservices.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

Tri-State Health Services is a private, single-site outpatient addiction medicine clinic in Washington, Pennsylvania that provides medication-assisted treatment for opioid addiction using buprenorphine and naltrexone products, serving patients across Pennsylvania, Ohio, and West Virginia.

Ownership category

akta.pro rank

Product category

Outpatient Opioid Addiction Treatment

NAICS

Outpatient Mental Health and Substance Abuse Centers (62142)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs) (HLAFACAG)

akta.pro secondary industries

Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD), Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

Keywords

• Medication-assisted treatment
• Opioid addiction treatment
• Buprenorphine therapy
• Outpatient addiction services
• Substance abuse counseling

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Healthcare Services Revenue: The company generates revenue through providing medication-assisted treatment services for opioid addiction. Services include office-based treatment using buprenorphine products (Suboxone, Zubsolv, Bunavail, Subutex) and naltrexone (Vivitrol), along with associated clinical consultations and follow-up care.

Distribution channels1 record

Marketing channels1 record

Core offering

Tri-State Health Services provides medication-assisted treatment (MAT) for opioid addiction at a single outpatient clinic in Washington, PA. Treatment combines FDA-approved buprenorphine/naloxone products (Suboxone, Zubsolv, Bunavail), buprenorphine-only Subutex, and naltrexone (Vivitrol) with psychotherapy, counseling, and ongoing maintenance programs for patients addicted to prescription pain medications and heroin.

Product overview

Tri-State Health Services provides medication-assisted treatment (MAT) for opioid addiction through a combination of FDA-approved medications and supportive counseling. The company offers a portfolio of branded and generic buprenorphine-based medications including Suboxone, Zubsolv, and Bunavail (buprenorphine/naloxone combinations), Subutex (buprenorphine-only), and Vivitrol (naltrexone). These medications work alongside psychotherapy and support services to treat individuals addicted to prescription pain medications and heroin. Treatment includes initial detoxification and ongoing maintenance programs, with flexible scheduling including evening and weekend appointments.

Differentiator

Problem solved

Functional benefit

Products and services

• Medication-Assisted Treatment (MAT) Program Comprehensive outpatient treatment program for individuals addicted to prescription pain medications and/or heroin, combining buprenorphine-based medications and naltrexone with psychotherapy and support services.
• Opioid Detoxification Services Medication-assisted detoxification for patients dependent on opioids, provided by certified doctors at the Washington, PA office.
• Buprenorphine Maintenance Program Long-term maintenance program using buprenorphine products delivered in connection with local Community Service Boards to help patients avoid relapse following initial opioid detoxification.
• Psychotherapy and Counseling Services Psychotherapy and non faith-based counseling offered alongside medication treatment to enhance recovery outcomes and address patients who have not succeeded with faith-based or 12-step programs.
• Court and Legal Compliance Documentation Documentation of client treatment compliance for courts and legal issues, available to patients navigating legal matters related to their addiction treatment.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Acadia Healthcare: National behavioral health operator with psychiatric and substance use treatment facilities across the U.S. Overlaps with Tri-State on substance use treatment but at vastly larger scale and broader service mix.
• Pinnacle Treatment Centers: Large multi-state addiction treatment provider offering outpatient MAT, residential, and detox services. Overlaps with Tri-State on outpatient MAT, but operates at significantly larger scale with broader service portfolio.

Direct peers

• Eleanor Health: Outpatient addiction treatment provider combining MAT with counseling and case management across multiple locations. Comparable care model and patient population to Tri-State.
• Groups: Recover Together: Outpatient MAT chain providing office-based buprenorphine treatment combined with group therapy. Highly comparable model (medication + group counseling) to Tri-State's MAT-plus-psychotherapy approach.
• BrightView Health: Outpatient addiction treatment provider with multiple clinics across the Midwest and East Coast delivering MAT, counseling, and case management. Directly comparable outpatient MAT service offering and patient population to Tri-State.
• BAART Programs: Multi-state opioid treatment program (OTP) network (part of BayMark Health) operating office-based MAT and methadone services. Directly comparable service offering and patient base to Tri-State's MAT clinic.
• Ideal Option: Multi-state office-based MAT provider offering buprenorphine/suboxone across rural and mid-size markets. Comparable service mix, patient segment, and geographic targeting (underserved areas) to Tri-State.
• CleanSlate Centers: Multi-state office-based opioid treatment provider offering buprenorphine and naltrexone MAT across dozens of clinics. Closely comparable to Tri-State's office-based MAT model, but operates at much larger regional scale.

Emerging players

• Bicycle Health: Virtual MAT provider delivering buprenorphine treatment via telehealth across multiple states. Same medication-assisted treatment modality and target patient population as Tri-State, but remote delivery model.
• Workit Health: Telemedicine-first MAT provider offering buprenorphine treatment via virtual visits. Comparable patient population and medication regimen, but competing via a delivery model that Tri-State does not currently offer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/tshealthservices

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tri-State Health Services